Showing 20,841 - 20,860 results of 21,467 for search '(( 5 ((point decrease) OR (nn decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.49s Refine Results
  1. 20841

    Video_10_Additional Improvement of Respiratory Technique on Vascular Function in Hypertensive Postmenopausal Women Following Yoga or Stretching Video Classes: The YOGINI Study.MOV by Cláudia Fetter (9315074)

    Published 2020
    “…However, resting heart rate and PWV [baseline: Y+: 10.44 ± 3.69 and S+: 9.50 ± 0.53 m/s vs. post: Y+: 9.45 ± 0.39 (p = 0.003) and S+: 8.02 ± 0.47 m/s (p = 0.003)] decreased significantly only in the Y+ and S+ groups (baseline vs. post). …”
  2. 20842

    Video_11_Additional Improvement of Respiratory Technique on Vascular Function in Hypertensive Postmenopausal Women Following Yoga or Stretching Video Classes: The YOGINI Study.MOV by Cláudia Fetter (9315074)

    Published 2020
    “…However, resting heart rate and PWV [baseline: Y+: 10.44 ± 3.69 and S+: 9.50 ± 0.53 m/s vs. post: Y+: 9.45 ± 0.39 (p = 0.003) and S+: 8.02 ± 0.47 m/s (p = 0.003)] decreased significantly only in the Y+ and S+ groups (baseline vs. post). …”
  3. 20843

    Video_5_Additional Improvement of Respiratory Technique on Vascular Function in Hypertensive Postmenopausal Women Following Yoga or Stretching Video Classes: The YOGINI Study.MOV by Cláudia Fetter (9315074)

    Published 2020
    “…However, resting heart rate and PWV [baseline: Y+: 10.44 ± 3.69 and S+: 9.50 ± 0.53 m/s vs. post: Y+: 9.45 ± 0.39 (p = 0.003) and S+: 8.02 ± 0.47 m/s (p = 0.003)] decreased significantly only in the Y+ and S+ groups (baseline vs. post). …”
  4. 20844

    Thermal load of main components during parking. by Weijian Li (762796)

    Published 2022
    “…<p>During the radiation increasing, the relationship between the solar radiation and the components temperature follows as: atmosphere, <i>T</i><sub><i>atm</i></sub> = 0.006086<i>I</i><sup>1.117</sup> + 25.95; cabin air, <i>T</i><sub><i>ca</i></sub> = 0.006086<i>I</i><sup>1.117</sup> + 25.95; the steering wheel, <i>T</i><sub><i>Sw</i></sub> = 0.1161<i>I</i><sup>0.9124</sup> + 20.69; front seat, <i>T</i><sub><i>s</i>1</sub> = 2.475<i>I</i><sup>4</sup> + 0.3333<i>I</i><sup>3</sup>−9.094<i>I</i><sup>2</sup> + 10.64<i>I</i> + 50.25; rear seat, <i>T</i><sub><i>s</i>2</sub> = −0.1648<i>I</i><sup>2</sup> + 10.35<i>I</i> + 40.8; During the radiation decreasing, the correlation follows as: atmosphere ; steering wheel <i>T</i><sub><i>Sw</i></sub> = 1.739<i>I</i><sup>0.4881</sup> + 33.89; front seat <i>T</i><sub><i>s</i>1</sub> = −1.886<i>I</i><sup>4</sup> + 0.8018<i>I</i><sup>3</sup> + 4.752<i>I</i><sup>2</sup> + 6.391<i>I</i> + 53.98; rear seat <i>T</i><sub><i>s</i>2</sub> = −0.8943<i>I</i><sup>4</sup> + 1.891<i>I</i><sup>3</sup> + 1.865<i>I</i><sup>2</sup> + 1.704<i>I</i> + 51.24. …”
  5. 20845

    Image_1_Additional Improvement of Respiratory Technique on Vascular Function in Hypertensive Postmenopausal Women Following Yoga or Stretching Video Classes: The YOGINI Study.jpg by Cláudia Fetter (9315074)

    Published 2020
    “…However, resting heart rate and PWV [baseline: Y+: 10.44 ± 3.69 and S+: 9.50 ± 0.53 m/s vs. post: Y+: 9.45 ± 0.39 (p = 0.003) and S+: 8.02 ± 0.47 m/s (p = 0.003)] decreased significantly only in the Y+ and S+ groups (baseline vs. post). …”
  6. 20846

    Esophageal Lengthening in Paraesophageal Hernia Repair by Sadia Tasnim (8729219)

    Published 2024
    “…However, its major advantage is that there is no resection of the stomach and decreased risk of a redundant neoesophagus.</p><p dir="ltr"><b>Reference(s)</b></p><p dir="ltr">Horvath, Karen D. …”
  7. 20847

    DataSheet_1_Low-Salt Diet Attenuates B-Cell- and Myeloid-Cell-Driven Experimental Arthritides by Affecting Innate as Well as Adaptive Immune Mechanisms.docx by Bettina Sehnert (23407)

    Published 2021
    “…LS diet reduced anti-CII IgG2a levels in CIA and decreased the anti-CII IgG2a/IgG1 ratios pointing toward a more Th2-like response. …”
  8. 20848

    Sequence space coverage (SSC) largely depends on genome length and GC-content. by Yuval Bussi (11565280)

    Published 2021
    “…SSC decreases as GC-content differs from the random, 0.5 (bright green).…”
  9. 20849

    Fig 3 - by Amanda L. Laverty (9248648)

    Published 2020
    “…Water temperature ranged from 2.1–9.5°C. Note the decreased range of the Y-axis relative to Fig 3A. …”
  10. 20850
  11. 20851

    Total Robotic Pericardiectomy for Constrictive Pericarditis by Jett, G. Kimble (5419655)

    Published 2023
    “…J Laparoendosc Adv Surg Tech A 2006;16:518-21.</p><p dir="ltr">5. Luison F, Boyd WD. …”
  12. 20852

    Data Sheet 3_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
  13. 20853

    Data Sheet 1_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
  14. 20854

    Data Sheet 8_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
  15. 20855

    Data Sheet 9_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
  16. 20856

    Data Sheet 4_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
  17. 20857

    Epidural Hydromorphone for Postpartum Pain Management After Vaginal Delivery: A Randomized Clinical Trial by Yixing Lu (19234084)

    Published 2025
    “…Postpartum analgesic medication requirements were reduced in the HY group (6.79% vs. 24.77%; OR 0.39, 95% CI 0.25-0.61), and the time to first additional analgesic was prolonged (15.63 ± 5.98 vs. 12.01 ± 5.01 h). However, the HY group exhibited increased rates of nausea and vomiting (26.24% vs. 8.11%; RR 1.72, 95% CI 1.45-2.04), dizziness (25.34% vs. 14.41%; RR 1.34, 95% CI 1.13-1.66), pruritus (32.58% vs. 7.21%; RR 1.95, 95% CI 1.67-2.28), and urinary retention (20.81% vs. 7.66%; RR 1.59, 95% CI 1.32-1.91). …”
  18. 20858

    Data Sheet 7_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
  19. 20859

    Data Sheet 11_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

    Published 2025
    “…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
  20. 20860

    Figure 3 from Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway Modulation by Anna Rutkowska (19676837)

    Published 2025
    “…<i>P</i> < 0.05, |log<sub>2</sub> fc| > log<sub>2</sub> (1.5)] modulated ones are indicated with name. Niraparib decreases CYP51A1 (lanosterol 14α-demethylase) enzyme levels (Supplementary Fig. …”